GPER1 and cancer: Our study findings demonstrate that across the 10 studied cancer types, GPER1 exhibits high methylation in 5 cancers (BRCA, ESCA, HNSC, LUAD, and UCEC) and low methylation in 3 cancers (KIRC, KIRP, and PAAD).